Sunshine Biopharma (SBFM) Asset Utilization Ratio (2018 - 2026)
Sunshine Biopharma's (SBFM) quarterly Asset Utilization Ratio came in at 1.22 in Q1 2026, up 0.89% YoY from 1.21 in Q1 2025, and up 3.76% on a QoQ basis from 1.18 in Q4 2025.
Sunshine Biopharma (SBFM) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 9 years of Asset Utilization Ratio data on file, last reported at 1.22 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 0.89% year-over-year to 1.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.22 (up 0.89% YoY) and the FY2025 annual result came in at 1.2, down 0.59% from the prior year.
- Asset Utilization Ratio advanced to 1.22 in Q1 2026, from 1.18 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.22 in Q1 2026 to a low of 0.01 in Q3 2022.
- A 5-year average of 0.75 and a median of 0.9 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio slumped 85.06% — and 2023, when it soared 6027.84%.
- Tracing SBFM's Asset Utilization Ratio over 5 years: stood at 0.12 in 2022, then soared by 606.75% to 0.88 in 2023, then jumped by 31.33% to 1.15 in 2024, then advanced by 2.5% to 1.18 in 2025, then grew by 3.76% to 1.22 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.22 (Q1 2026), 1.18 (Q4 2025), and 1.18 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 1.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 |
| Mar 31, 2026 | 1.22 |
| Dec 31, 2025 | 1.18 |
| Sep 30, 2025 | 1.18 |
| Jun 30, 2025 | 1.19 |
| Mar 31, 2025 | 1.21 |
| Dec 31, 2024 | 1.15 |
| Sep 30, 2024 | 1.11 |
| Jun 30, 2024 | 1.00 |
| Mar 31, 2024 | 0.90 |
| Dec 31, 2023 | 0.88 |
| Sep 30, 2023 | 0.73 |
| Jun 30, 2023 | 0.52 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | 0.08 |